| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.327 | 5.336 | 35.112 | 25.925 | 35.124 | 24.205 | 22.751 | 25.329 | 12.734 | 10.995 |
| Total Income - EUR | 11.327 | 5.336 | 35.112 | 26.414 | 37.321 | 24.590 | 22.630 | 25.907 | 12.734 | 10.995 |
| Total Expenses - EUR | 3.757 | 2.198 | 1.039 | 7.553 | 4.760 | 5.594 | 4.139 | 3.979 | 2.408 | 1.272 |
| Gross Profit/Loss - EUR | 7.570 | 3.138 | 34.074 | 18.861 | 32.562 | 18.995 | 18.491 | 21.928 | 10.326 | 9.722 |
| Net Profit/Loss - EUR | 7.231 | 2.978 | 33.021 | 18.068 | 31.442 | 18.257 | 17.812 | 21.167 | 8.660 | 8.354 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vice Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.942 | 10.579 | 10.205 | 13.051 | 21.959 | 20.643 | 17.325 | 15.146 | 13.242 | 17.841 |
| Current Assets | 18.894 | 14.539 | 41.576 | 54.017 | 29.635 | 48.361 | 19.257 | 24.593 | 20.444 | 23.253 |
| Inventories | 123 | 0 | 189 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 490 | 1.611 | 259 | 254 | 963 | 245 | 240 | 8.785 | 3.638 | 4.608 |
| Cash | 18.281 | 12.928 | 41.128 | 53.763 | 28.671 | 48.116 | 19.018 | 15.808 | 16.806 | 18.645 |
| Shareholders Funds | 27.883 | 16.326 | 49.070 | 66.238 | 49.254 | 66.577 | 35.754 | 27.223 | 28.726 | 37.898 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 2.023 | 8.860 | 2.779 | 897 | 2.405 | 2.490 | 891 | 12.578 | 4.960 | 3.196 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Vice Med Srl